Skip to Content

New Drug Approvals Archive - May 2010

See also: New Indications and Dosage Forms for May 2010

May 2010

Natazia (dienogest and estradiol valerate) - formerly Qlaira

Date of Approval: May 6, 2010
Company: Bayer HealthCare Pharmaceuticals Inc.
Treatment for: Contraception, Heavy Menstrual Bleeding

Natazia (dienogest and estradiol valerate) is a combination oral contraceptive indicated for use by women to prevent pregnancy and to treat heavy menstrual bleeding.

Sprix (ketorolac tromethamine) Nasal Spray - formerly ROX-888

Date of Approval: May 14, 2010
Company: Egalet Corporation
Treatment for: Pain

Sprix (ketorolac tromethamine) is an intranasal analgesic for the management of acute moderate to severe pain.

Zymaxid (gatifloxacin) Ophthalmic Solution

Date of Approval: May 18, 2010
Company: Allergan, Inc.
Treatment for: Bacterial Conjunctivitis

Zymaxid (gatifloxacin ophthalmic) is a fluoroquinolone anti-infective indicated for the treatment of bacterial conjunctivitis.

Lumizyme (alglucosidase alfa)

Date of Approval: May 24, 2010
Company: Genzyme Corporation
Treatment for: Pompe disease

Lumizyme (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for patients with Pompe disease.

Cysview (hexaminolevulinate) for Intravesical Solution - formerly Hexvix

Date of Approval: May 28, 2010
Company: Photocure ASA
Treatment for: Diagnostic

Cysview (hexaminolevulinate HCl) is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder.

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.